Melissa Kolski

Melissa Kolski

Auto-generated profile, based on publicly available information

Melissa Kolski

Feinberg School of Medicine, Northwestern University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2022 in Pain
Verified
Journal Article
Closed access
MSMuath A. Shraim
Muath A. Shraim
KSKathleen A. Sluka
Kathleen A. Sluka
MSMichele Sterling
Michele Sterling
LALars Arendt-Nielsen
Lars Arendt-Nielsen
CACharles Argoff
Charles Argoff
PHPaul Hodges
Paul Hodges
Classification of musculoskeletal pain based on underlying pain mechanisms (nociceptive, neuropathic, and nociplastic pain) is challenging. In the absence of a gold standard, verification of features that could aid in discrimination between these mechanisms in clinical practice and research depends on expert consensus. This Delphi expert consensus study aimed to: (1) identify features and assessment findings that are unique to a pain mechanism category or shared between no more than 2 categories and (2) develop a ranked list of candidate features that could potentially discriminate between pain mechanisms. A group of international experts were recruited based on their expertise in the field of pain. The Delphi process involved 2 rounds: round 1 assessed expert opinion on features that are unique to a pain mechanism category or shared between 2 (based on a 40% agreement threshold); and round 2 reviewed features that failed to reach consensus, evaluated additional features, and considered wording changes. Forty-nine international experts representing a wide range of disciplines participated. Consensus was reached for 196 of 292 features presented to the panel (clinical examination—134 features, quantitative sensory testing—34, imaging and diagnostic testing—14, and pain-type questionnaires—14). From the 196 features, consensus was reached for 76 features as unique to nociceptive (17), neuropathic (37), or nociplastic (22) pain mechanisms and 120 features as shared between pairs of pain mechanism categories (78 for neuropathic and nociplastic pain). This consensus study generated a list of potential candidate features that are likely to aid in discrimination between types of musculoskeletal pain.

1 December 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
JFJoel Fundaun
Joel Fundaun
MKMelissa Kolski
Melissa Kolski
MMMiguel Molina-Alvarez
Miguel Molina-Alvarez
GBGeorgios Baskozos
Georgios Baskozos
ASAnnina B Schmid
Annina B Schmid
Importance: Peripheral neuropathies are common conditions and can result in numbness, paresthesia, motor deficits, and pain. There is increasing evidence for the use of biomarkers as clinical indicators of the presence, severity, and prognosis of nerve lesions; however, biomarker identification has largely been focused on disorders of the central nervous system, and less is known about their role in the peripheral nervous system.Objective: To assess blood-based biomarker concentrations associated with nerve involvement in patients with peripheral neuropathy compared with control participants.Data Sources: Ovid, MEDLINE, Embase, and CINAHL were searched from inception to September 23, 2021.Study Selection: Observational studies reporting on blood biomarkers in patients diagnosed with peripheral neuropathy were included. This review was preregistered on PROSPERO and followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline. Data were abstracted by 1 investigator and independently reviewed by a second.Data Extraction and Synthesis: Data were meta-analyzed when at least 2 studies reported the same biomarker with comparable methodology. Fixed-effects models were used when only 2 studies were included; random-effects models were used when more than 2 studies were included.Main Outcomes and Measures: The outcome of interest was concentration of biomarkers.Results: This review included 36 studies reporting on 4414 participants, including 2113 control participants and 2301 patients with peripheral neuropathy with 13 distinct peripheral neuropathy diagnoses. Diabetic neuropathy was the most common neuropathy diagnosis (13 studies), followed by Charcot-Marie-Tooth disease (6 studies) and Guillain-Barre syndrome (6 studies). Overall, 16 different blood-based biomarkers associated with nerve involvement were evaluated. The most used were neurofilament light chain, S100B, brain-derived neurotrophic factor, and neuron-specific enolase. Patients with peripheral neuropathy demonstrated significantly higher levels of neurofilament light chain compared with controls (standardized mean difference [SMD], 0.93 [95% CI, 0.82 to 1.05];P < .001). There were no significant differences in levels of S100B (SMD, 1.10 [95% CI, −3.08 to 5.28];P = .38), brain-derived neurotrophic factor (SMD, −0.52 [95% CI, −2.23 to 1.19];P = .40), or neuron-specific enolase (SMD, −0.00 [95% CI, −1.99 to 1.98];P = .10) in patients with peripheral neuropathy compared with control participants.Conclusions and Relevance: The findings of this systematic review and meta-analysis support the use of neurofilament light chain as a blood-based measure associated with the presence of neuronal injury in patients with peripheral neuropathy.

12 October 2021 in Pain
Verified
Journal Article
Open access
JFJoel Fundaun
Joel Fundaun
MKMelissa Kolski
Melissa Kolski
GBGeorgios Baskozos
Georgios Baskozos
ADAndrew Dilley
Andrew Dilley
MSMichele Sterling
Michele Sterling
ASAnnina B Schmid
Annina B Schmid
There is no clear understanding of the mechanisms causing persistent pain in patients with whiplash-associated disorder (WAD). The aim of this systematic review was to assess the evidence for nerve pathology and neuropathic pain in patients with WAD. EMBASE, PubMed, CINAHL (EBSCO), and MEDLINE were searched from inception to September 1, 2020. Study quality and risk of bias were assessed using the Newcastle–Ottawa Quality Assessment Scales. Fifty-four studies reporting on 390,644 patients and 918 controls were included. Clinical questionnaires suggested symptoms of predominant neuropathic characteristic in 34% of patients (range 25%-75%). The mean prevalence of nerve pathology detected with neurological examination was 13% (0%-100%) and 32% (10%-100%) with electrodiagnostic testing. Patients independent of WAD severity (Quebec Task Force grades I-IV) demonstrated significantly impaired sensory detection thresholds of the index finger compared with controls, including mechanical (SMD 0.65 [0.30; 1.00] P < 0.005), current (SMD 0.82 [0.25; 1.39] P = 0.0165), cold (SMD −0.43 [−0.73; −0.13] P = 0.0204), and warm detection (SMD 0.84 [0.25; 1.42] P = 0.0200). Patients with WAD had significantly heightened nerve mechanosensitivity compared with controls on median nerve pressure pain thresholds (SMD −1.10 [−1.50; −0.70], P < 0.0001) and neurodynamic tests (SMD 1.68 [0.92; 2.44], P = 0.0004). Similar sensory dysfunction and nerve mechanosensitivity was seen in WAD grade II, which contradicts its traditional definition of absent nerve involvement. Our findings strongly suggest a subset of patients with WAD demonstrate signs of peripheral nerve pathology and neuropathic pain. Although there was heterogeneity among some studies, typical WAD classifications may need to be reconsidered and include detailed clinical assessments for nerve integrity.

27 March 2025 in PM&R
Verified
Journal Article
Open access
OSOlumide Sokunbi
Olumide Sokunbi
KOKevin Ozment
Kevin Ozment
KLKelsey LeFevour
Kelsey LeFevour
DDDerek Daniels
Derek Daniels
MKMelissa Kolski
Melissa Kolski
PJPrakash Jayabalan
Prakash Jayabalan
Background: Studies have shown that athletes with disabilities (AWDs) are often not provided with injury prevention and health promotion strategies via educational programs.Objective: To assess the impact of a novel educational interventional workshop on the healthy lifestyle knowledge and implementation in a cohort of AWDs using a community‐based participatory research approach. We hypothesized that the Adaptive Health Education on Activity and Diet workshop would increase the participation of AWDs in healthy exercise and diet.Methods: Participants enrolled in this educational interventional prospective cohort study consisted of AWDs participating in an urban adaptive sports program. The intervention included eight virtual educational sessions regarding nutrition, strength training, cardiovascular exercise, and health optimization taught by a multidisciplinary team. The outcome measures were participation in healthy lifestyle regarding diet and exercise, Patient‐Reported Outcomes Measurement Information System (PROMIS)‐29, and Godin Exercise scores.Results: The mean age of the adaptive athletes (n = 26) was 50.1 years (SD 15.4), with 50% male and 50% female. Primary disability diagnoses included spinal cord injury, brain injury, stroke, amputation, and cerebral palsy. The baseline physical function level PROMIS‐29 scores had a sustained increase (increase from pre to post to follow‐up) after the intervention (p < .05). There was a nonsustained increase from pre to post intervention (p < .05) in frequency of meal preparation and discussion of diet and exercise with a primary care physician. There was an overall increase in frequency of weight training three or more times a week (p < .05).Discussion: Our findings were consistent with our hypothesis that the workshop would increase participation in healthy diet and exercise. The significant improvements were in frequency of meal prep, weight training, and discussions of diet and exercise with primary care physicians.Conclusion: Providing healthy lifestyle information through an educational workshop tailored to the community's needs, using a community‐based participatory research approach, can improve nutrition and exercise participation of AWDs.

1 April 2024 in Annals of Internal Medicine: Clinical Cases
Verified
Journal Article
Closed access
VAVikas Agarwal
Vikas Agarwal
ABAjay Bansal
Ajay Bansal
MKMelissa Kolski
Melissa Kolski

6 July 2026 in Journal of International Medical Research
Verified
Journal Article
Open access
KBKian Bagheri
Kian Bagheri
ARAlex Reid
Alex Reid
DDDane N Daley
Dane N Daley
EEEvert Austin Eriksson
Evert Austin Eriksson
MKMelissa C Kolski
Melissa C Kolski
MSMatthew C Sherrier
Matthew C Sherrier
The abdominal wall musculature, including the rectus abdominis, transversus abdominis, and internal and external obliques, is a complex, multifunctional unit essential for trunk stability, postural control, and respiratory function. Injury to the intercostal nerves innervating these muscles, which may occur following rib fractures, thoracic surgery, trauma, or iatrogenic interventions, can lead to significant motor and respiratory deficits, including abdominal wall bulging, reduced trunk stability, impaired cough, and diminished forced expiration. Surgical interventions such as intercostal nerve exploration and neurolysis with possible direct neurorrhaphy versus allograft nerve reconstruction offer the potential for reinnervation; however, successful functional recovery depends on structured, targeted rehabilitation. This narrative review synthesizes current knowledge on abdominal wall anatomy, intercostal nerve injury consequences, surgical repair strategies, and rehabilitation principles, focusing on abdominal wall-specific recovery. It proposes a phased rehabilitation framework that integrates motor retraining, respiratory optimization, cortical plasticity–guided techniques, and functional retraining. Objective outcome measures, including ultrasound, electrodiagnostic testing, and timed leg-lowering tests and respiratory metrics such as peak cough flow, can guide and track recovery. By combining neuroplasticity-driven interventions, respiratory integration, and progressive, task-specific retraining, clinicians may optimize functional outcomes for patients following intercostal nerve injury. Future research should prioritize the standardization of assessment methods and validation of structured rehabilitation protocols.